跳至主要内容
临床试验/EUCTR2020-004705-31-DK
EUCTR2020-004705-31-DK进行中(未招募)1 期

ong-term follow-up study of immune response to vaccinations with RV001 in patients enrolled in RhoVac-001 study

RhoVac ApS0 个研究点目标入组 22 人开始时间: 2021年1月7日最近更新:
适应症

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
RhoVac ApS
入组人数
22

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Male

入选标准

  • 1) Patients who previously participated in RhoVac-001 study.
  • 2) Patients who have provided written informed consent.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 3
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 19

排除标准

  • 3) Health conditions which in the opinion of the investigator will preclude the patient from participating in the study.

研究者

发起方
RhoVac ApS

相似试验